The evidence supports a multimodal approach combining exercise, sleep optimization, nutrition, cognitive training, and mindfulness as the most effective strategy for improving mental clarity and reducing brain fog.[1][2][3]
Exercise
Physical activity has the strongest evidence base. A network meta-analysis found that resistance exercise had the highest probability of being the most effective intervention for preserving global cognition (SMD 1.05), executive function (SMD 0.85), and memory (SMD 0.32), followed by multicomponent and aerobic exercise.[4] Exercise exerts neuroprotective effects through BDNF-TrkB signaling, hippocampal neurogenesis, and improved synaptic plasticity.[1] Even moderate aerobic activity improves cerebral perfusion and attention.
Sleep Quality
Slow-wave sleep is critical for glymphatic clearance of metabolic waste products (including amyloid-β and tau), and poor sleep is directly linked to impaired concentration and cognitive performance.[1][3] Good sleep hygiene practices — consistent schedules, blue-light reduction, and addressing sleep disorders — are foundational.
Nutrition
Dietary patterns matter more than individual supplements. The Mediterranean and MIND diets have the strongest evidence for cognitive protection, emphasizing fish, vegetables, fruits, nuts, and olive oil.[5] Specific nutrients with supporting evidence include:
– Omega-3 fatty acids and B vitamins (particularly folate) — associated with improved executive function and slower cognitive decline[6][4]
– Flavonoids and polyphenols (found in berries, tea, dark chocolate) — antioxidant and anti-inflammatory neuroprotective effects[6][7]
– Moderate caffeine — can acutely improve alertness and concentration[8]
Cognitive Training and Mindfulness
Mindfulness-based stress reduction (MBSR) may enhance working memory and reduce stress-related cortisol, which impairs prefrontal cortical function.[9][10] Cognitive training programs improve attention, psychomotor function, and executive function, with simultaneous physical-cognitive training being the most efficacious combined approach.[4] A randomized trial (JAMA, 2022) evaluated MBSR and exercise in older adults, finding both interventions showed promise for cognitive maintenance.[9]
Hydration and Vascular Risk Factor Management
Controlling hypertension, diabetes, and dyslipidemia is important for preserving cerebrovascular health and cognitive function.[11][12] Even mild dehydration can impair concentration and working memory.
Pharmacologic Options for Persistent Brain Fog
When lifestyle measures are insufficient, limited pharmacologic options exist. For fatigue-associated brain fog, cognitive pacing is first-line, with occasional use of modafinil, methylphenidate, or amantadine considered in select cases.[8] In long-COVID brain fog specifically, the combination of guanfacine (an α2A-adrenoceptor agonist that strengthens prefrontal cortical connections) and N-acetylcysteine (NAC, an antioxidant) has shown promising early results.[13] Citicoline (1000 mg/day) has also demonstrated benefit in case reports.[13]
The FINGER trial and the more recent Maintain Your Brain study demonstrated that multidomain interventions addressing diet, exercise, cognitive stimulation, and vascular risk factors simultaneously provide greater cognitive benefit than any single intervention alone.[11][12]
References
[1] A Multimodal Framework for Alzheimer’s Prevention: Diet, Exercise, Fasting, Sleep, and Gut Microbiota. Kurmi S, Shirodkar S, Parab SB, Doshi G. Current Alzheimer Research. 2026;:CAR-EPUB-155237. doi:10.2174/0115672050467997260323164241.
[2] Effects of Non-Pharmacological Interventions for Adults With Subjective Cognitive Decline: A Network Meta-Analysis and Component Network Meta-Analysis. Yu XH, Li XR, Du ZR, et al. BMC Medicine. 2024;22(1):272. doi:10.1186/s12916-024-03491-z.
[3] Boosting Brain Health: Interventions for the Prevention and Treatment of Mild Cognitive Impairment and Early Neurodegenerative Disease. Bushnell ML, Roberts NA, Caraher K. Neurologic Clinics. 2024;42(4):943-958. doi:10.1016/j.ncl.2024.05.014.
[4] The Impact of Cognitive Impairment on Cardiovascular Disease. Jamil Y, Krishnaswami A, Orkaby AR, et al. Journal of the American College of Cardiology. 2025;85(25):2472-2491. doi:10.1016/j.jacc.2025.04.057.
[5] Nutrition and Prevention of Cognitive Impairment. Scarmeas N, Anastasiou CA, Yannakoulia M. The Lancet. Neurology. 2018;17(11):1006-1015. doi:10.1016/S1474-4422(18)30338-7.
[6] Functional Nutrition: A Non-Pharmacological Approach to Supporting Cognitive Health. Tultabayev M, Zhumanova U, Tultabayeva T, Shoman A. Scientific Reports. 2026;:10.1038/s41598-026-47569-5. doi:10.1038/s41598-026-47569-5.
[7] Botanicals and Phytochemicals Active on Cognitive Decline: The Clinical Evidence. Cicero AFG, Fogacci F, Banach M. Pharmacological Research. 2018;130:204-212. doi:10.1016/j.phrs.2017.12.029.
[8] Fatigue in Adults: Evaluation and Management. Latimer KM, Gunther A, Kopec M. American Family Physician. 2023;108(1):58-69.
[9] Effects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial. Lenze EJ, Voegtle M, Miller JP, et al. JAMA. 2022;328(22):2218-2229. doi:10.1001/jama.2022.21680.
[10] Mindfulness and Cognitive Training Interventions in Mild Cognitive Impairment: Impact on Cognition and Mood. Reynolds GO, Willment K, Gale SA. The American Journal of Medicine. 2021;134(4):444-455. doi:10.1016/j.amjmed.2020.10.041.
[11] Strategies for the use of Ginkgo biloba extract, EGb 761 ® , in the treatment and management of mild cognitive impairment in Asia: Expert consensus. Kandiah N, Chan YF, Chen C, et al. CNS Neuroscience & Therapeutics. 2021;27(2):149-162. doi:10.1111/cns.13536.
[12] Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia. Goodall LS, Lennon MJ, Sachdev PS, et al. Journal of the American College of Cardiology. 2026;87(1):77-100. doi:10.1016/j.jacc.2025.09.1502.
[13] Cognitive Sequelae of COVID ‐19: Mechanistic Insights and Therapeutic Approaches. Chen YH, Jan JS, Yang CH, et al. CNS Neuroscience & Therapeutics. 2025;31(3):e70348. doi:10.1111/cns.70348.